Possible determinants of VSL#3 probiotic failure in preventing gastrointestinal adverse events associated with dacomitinib in patients with advanced non-small-cell lung cancer enrolled in ARCHER-1042 trial

Ann Oncol. 2016 Nov;27(11):2137-2138. doi: 10.1093/annonc/mdw298. Epub 2016 Aug 8.

¹ Department of Public Health and Infectious Diseases, 'Sapienza' University of Rome, Rome, Italy.
² Department of Public Health and Infectious Diseases, 'Sapienza' University of Rome, Rome, Italy ivan.schietroma@uniroma1.it.

No abstract available

Publication types